Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
990 INR | +1.59% | -2.57% | +22.01% |
May. 08 | AstraZeneca, Merck Sue to Protect Lynparza Cancer Drug Patents | MT |
May. 08 | AstraZeneca, Merck Sue to Protect Lynparza Cancer Drug Patents | MT |
Business Summary
Number of employees: 3,946
Sales per Business
INR in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Pharmaceuticals
98.5
%
| 19,399 | 99.7 % | 26,662 | 98.5 % | +37.44% |
Agro Chemicals
1.5
%
| 49 | 0.3 % | 409 | 1.5 % | +734.69% |
Sales per region
INR in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
59.3
%
| 9,782 | 50.3 % | 16,060 | 59.3 % | +64.18% |
Rest of the World
22.2
%
| 3,576 | 18.4 % | 5,997 | 22.2 % | +67.70% |
India
18.5
%
| 6,090 | 31.3 % | 5,014 | 18.5 % | -17.67% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 46 | 00-07-02 | |
Founder | 78 | 81-09-18 | |
Director of Finance/CFO | - | - | |
Chief Operating Officer | - | - | |
Compliance Officer | - | 22-03-31 | |
M. Pulla Reddy
CTO | Chief Tech/Sci/R&D Officer | 66 | 94-03-31 |
Chief Tech/Sci/R&D Officer | 71 | 93-02-10 | |
Director/Board Member | - | - | |
Director/Board Member | 66 | 14-11-11 | |
Sadasiva N. Rao
LAW | General Counsel | - | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Founder | 78 | 81-09-18 | |
Chief Executive Officer | 46 | 00-07-02 | |
Director/Board Member | 70 | 14-04-17 | |
Leela Digumarti
BRD | Director/Board Member | - | 14-09-21 |
M. U. R Naidu
BRD | Director/Board Member | 74 | 15-02-10 |
Chief Tech/Sci/R&D Officer | 71 | 93-02-10 | |
Director/Board Member | 66 | 14-11-11 | |
Director/Board Member | - | - |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 179,109,870 | 83,757,134 ( 46.76 %) | 0 | 46.76 % |
Company contact information
NATCO Pharma Ltd.
NATCO House Road No. 2
500034, Hyderabad
+91 40 2354 7532
http://www.natcopharma.co.inGroup companies
Name | Category and Sector |
---|---|
Natco Pharma (Canada), Inc.
|
Sector
Sales per Business
Sales per region
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+22.03% | 2.09B | |
+29.98% | 682B | |
+32.02% | 586B | |
-3.52% | 364B | |
+18.59% | 327B | |
+4.07% | 285B | |
+16.30% | 240B | |
+9.57% | 209B | |
-8.79% | 203B | |
+7.09% | 165B |
- Stock Market
- Equities
- NATCOPHARM Stock
- Company NATCO Pharma Limited